BIO-Europe 2026
Panel Clinical Strategy track
Capital with a Mission: Investing Beyond Traditional Venture Models
Wed, Nov 11, 2026 · 11:00–11:45 AM CET Clinical Strategy Stage, Koelnmesse
About this session
As innovation in neglected diseases like glioblastoma (GBM) and neuroblastoma struggles to attract traditional venture capital, alternative investment models are emerging that prioritize patient impact alongside financial returns. This panel examines how mission-driven investment approaches differ from—and complement—conventional venture models in supporting breakthrough therapies for underserved patient populations.
